Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Download
Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV: ₹37.906 (0.371%)
NAV on November 02, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets ₹1,511 cr
Turnover Ratio 65.05%
Expense Ratio 1.07%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: Negative return: -0.40%
  • 1Y: Positive return: 5.64%
  • 3M: Negative return: -4.73%
  • 3Y: Positive return: 19.06%
  • 6M: Positive return: 7.31%
  • 5Y: Positive return: 14.69%
Min Investment ₹5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since about 2 years)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 37.61
P/B Ratio 5.84
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR

Asset Allocation

  • Equity: 99.7%
  • Debt: 0.3%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -3.36
Beta 1.00
R-Squared 91.46
Info Ratio -0.85
Tracking Err 4.82
Sortino 1.321
Sharpe 0.792
Std Dev 16.553
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 11.49%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 87.28%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.23%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner Morningstar Logo – Data Partner
Visit AMC website to read all scheme related documents Tata Fund